Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Subatomic Particles03:37

Subatomic Particles

112.5K
Dalton was only partially correct about the particles that make up matter. All matter is composed of atoms, and atoms are composed of three smaller subatomic particles: protons, neutrons, and electrons. These three particles account for the mass and the charge of an atom.
112.5K
The Nucleosome Core Particle02:10

The Nucleosome Core Particle

14.1K
Nucleosomes are the DNA-histone complex, where the DNA strand is wound around the histone core. The histone core is an octamer containing two copies of H2A, H2B, H3, and H4 histone proteins.
The paradox
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their main responsibility is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. While on the other hand, they must allow polymerase enzymes to access DNA...
14.1K
The Nucleosome Core Particle01:12

The Nucleosome Core Particle

2.2K
Nucleosomes are the DNA-histone complex, where the DNA strand is wound around the histone core. The histone core is an octamer containing two copies of H2A, H2B, H3, and H4 histone proteins.
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their primary aim is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. On the other hand, they must allow polymerase enzymes to access histone-bound DNA during...
2.2K
Basic Postulates of Kinetic Molecular Theory: Particle Size, Energy, and Collision02:43

Basic Postulates of Kinetic Molecular Theory: Particle Size, Energy, and Collision

37.5K
The ideal-gas equation, which is empirical, describes the behavior of gases by establishing relationships between their macroscopic properties. For example, Charles’ law states that volume and temperature are directly related. Gases, therefore, expand when heated at constant pressure. Although gas laws explain how the macroscopic properties change relative to one another, it does not explain the rationale behind it.
37.5K
Equilibrium Conditions for a Particle01:23

Equilibrium Conditions for a Particle

2.2K
When an object is in equilibrium, it is either at rest or moving with a constant velocity. There are two types of equilibrium: static and dynamic. Static equilibrium occurs when an object is at rest, while dynamic equilibrium occurs when an object is moving with a constant velocity. In both cases, there must be a balance of forces acting on the object.
To understand the concept of equilibrium, let us first consider the forces acting on an object. When different forces act on an object, they can...
2.2K
Principle of Linear Impulse and Momentum for a System of Particles01:21

Principle of Linear Impulse and Momentum for a System of Particles

589
In the context of a system of particles moving relative to an inertial frame of reference, the equation of motion is a crucial tool for understanding the dynamics of the system. This equation, which accounts for external forces acting on each particle, plays a fundamental role in describing the system's behavior.
Notably, internal forces between particles, occurring in equal and opposite collinear pairs, cancel out and are not part of the equation of motion. This exclusion simplifies the...
589

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular insights into the formation of polymeric nanoassemblies of the anticancer peptide PEN-FFW.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Mapping Berberine distribution in liposomes: the role of drug-phospholipid interactions in localization and release.

International journal of pharmaceutics·2025
Same author

Chloroquine induces eryptosis in <i>P. falciparum</i>-infected red blood cells and the release of extracellular vesicles with a unique protein profile.

Frontiers in cellular and infection microbiology·2025
Same author

BioJect: An in vitro platform to explore release dynamics of peptides in subcutaneous drug delivery.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

An Adverse Outcome Pathway for food nanomaterial-induced intestinal barrier disruption.

Frontiers in toxicology·2025
Same author

The second phase of tumor invasion driven by immune cells: A study on doxorubicin-loaded PLG nanoparticles.

Journal of controlled release : official journal of the Controlled Release Society·2024
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

Related Experiment Video

Updated: Jan 23, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.4K

Nanomedicines - Tiny particles and big challenges.

Margareth R C Marques1, Qiuyi Choo2, Mukul Ashtikar3

  • 1United States Pharmacopeia, Rockville, USA.

Advanced Drug Delivery Reviews
|June 22, 2019
PubMed
Summary
This summary is machine-generated.

Nanotechnology in biomedicine offers benefits but poses risks. This review covers nanosafety assessment, characterization methods, and quality control for pharmaceutical nanomaterials.

More Related Videos

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.7K
Author Spotlight: Deciphering the Cognitive and Neural Mechanisms of Gesture in Communication
07:18

Author Spotlight: Deciphering the Cognitive and Neural Mechanisms of Gesture in Communication

Published on: January 26, 2024

1.3K

Related Experiment Videos

Last Updated: Jan 23, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

9.4K
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.7K
Author Spotlight: Deciphering the Cognitive and Neural Mechanisms of Gesture in Communication
07:18

Author Spotlight: Deciphering the Cognitive and Neural Mechanisms of Gesture in Communication

Published on: January 26, 2024

1.3K

Area of Science:

  • Biomedical nanotechnology
  • Pharmaceutical sciences
  • Regulatory science

Background:

  • Nanotechnology is widely applied in biomedical products like drugs and devices.
  • Potential toxicities of nanomaterials necessitate thorough safety assessments.
  • Regulatory bodies are addressing the risks associated with nanomaterials.

Purpose of the Study:

  • To review the regulatory landscape of nanosafety assessment.
  • To provide practical guidance on characterizing nanomaterials and drug formulations.
  • To discuss challenges in maintaining pharmaceutical quality during complex nanomanufacturing.

Main Methods:

  • Literature review of regulatory guidelines and scientific publications.
  • Synthesis of practical advice for nanomaterial characterization.
  • Discussion of quality control strategies in pharmaceutical nanotechnology.

Main Results:

  • Established regulatory frameworks for nanosafety are emerging.
  • Characterization is crucial for risk management of nanomaterials.
  • Monitoring pharmaceutical quality in complex nano-processes presents significant challenges.

Conclusions:

  • Balancing nanotechnology's opportunities and risks requires robust safety evaluations.
  • Standardized characterization methods are essential for regulatory compliance.
  • Ensuring consistent pharmaceutical quality demands advanced monitoring techniques.